These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26755431)

  • 1. Physicochemical property profile for brain permeability: comparative study by different approaches.
    Raevsky OA; Grigorev VY; Polianczyk DE; Sandakov GI; Solodova SL; Yarkov AV; Bachurin SO; Dearden JC
    J Drug Target; 2016 Aug; 24(7):655-62. PubMed ID: 26755431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS Multiparameter Optimization Approach: Is it in Accordance with Occam's Razor Principle?
    Raevsky OA
    Mol Inform; 2016 Apr; 35(3-4):94-8. PubMed ID: 27491918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain.
    Rankovic Z
    J Med Chem; 2017 Jul; 60(14):5943-5954. PubMed ID: 28388050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS drug design: balancing physicochemical properties for optimal brain exposure.
    Rankovic Z
    J Med Chem; 2015 Mar; 58(6):2584-608. PubMed ID: 25494650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution assessment of multiparameter optimization descriptors in CNS penetration.
    Raevsky OA; Grigorev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    SAR QSAR Environ Res; 2018 Oct; 29(10):785-800. PubMed ID: 30274532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2010 Jun; 1(6):435-49. PubMed ID: 22778837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational models to assign biopharmaceutics drug disposition classification from molecular structure.
    Khandelwal A; Bahadduri PM; Chang C; Polli JE; Swaan PW; Ekins S
    Pharm Res; 2007 Dec; 24(12):2249-62. PubMed ID: 17846869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico prediction of blood-brain barrier permeability.
    Yan A; Liang H; Chong Y; Nie X; Yu C
    SAR QSAR Environ Res; 2013 Jan; 24(1):61-74. PubMed ID: 23092117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
    Jiang L; Chen J; He Y; Zhang Y; Li G
    J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six global and local QSPR models of aqueous solubility at pH = 7.4 based on structural similarity and physicochemical descriptors.
    Raevsky OA; Grigorev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    SAR QSAR Environ Res; 2017 Aug; 28(8):661-676. PubMed ID: 28891683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technically Extended MultiParameter Optimization (TEMPO): An Advanced Robust Scoring Scheme To Calculate Central Nervous System Druggability and Monitor Lead Optimization.
    Ghose AK; Ott GR; Hudkins RL
    ACS Chem Neurosci; 2017 Jan; 8(1):147-154. PubMed ID: 27741392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors.
    Qu D; Yan A; Zhang JS
    SAR QSAR Environ Res; 2017 Feb; 28(2):111-132. PubMed ID: 28235391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    Mahar Doan KM; Humphreys JE; Webster LO; Wring SA; Shampine LJ; Serabjit-Singh CJ; Adkison KK; Polli JW
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1029-37. PubMed ID: 12438524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine.
    Hou T; Wang J; Li Y
    J Chem Inf Model; 2007; 47(6):2408-15. PubMed ID: 17929911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms.
    Doniger S; Hofmann T; Yeh J
    J Comput Biol; 2002; 9(6):849-64. PubMed ID: 12614551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Features of CNS Drugs Based on SVM and Greedy Algorithm.
    Zhang R; Ding Y
    Curr Comput Aided Drug Des; 2020; 16(6):725-733. PubMed ID: 31830888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Computer classification models on the relationship between chemical structures of compounds and drugs with their blood brain barrier penetration].
    Raevskiĭ OA; Solodova SL; Raevskaia OE; Liplavskiĭ IaV; Mannhold RM
    Biomed Khim; 2012; 58(3):246-56. PubMed ID: 22856130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lipophilic efficiency on compound quality.
    Tarcsay A; Nyíri K; Keseru GM
    J Med Chem; 2012 Feb; 55(3):1252-60. PubMed ID: 22229549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Passive Permeability of Drug-like Molecules from Chemical Structure: Where Are We?
    Broccatelli F; Salphati L; Plise E; Cheong J; Gobbi A; Lee ML; Aliagas I
    Mol Pharm; 2016 Dec; 13(12):4199-4208. PubMed ID: 27806577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.